Clinical Trials Logo

Cost Effectiveness clinical trials

View clinical trials related to Cost Effectiveness.

Filter by:

NCT ID: NCT01409551 Completed - Cost Effectiveness Clinical Trials

Video-assisted Hyperthermic Pleural Chemoperfusion vs Talc Pleurodesis for Refractory Malignant Pleural Effusions.

Start date: August 2011
Phase: N/A
Study type: Interventional

Aim of this study is to compare two methods of pleurodesis for refractory malignant pleural effusions, in terms of safety and efficacy.

NCT ID: NCT01303263 Completed - Cost-Effectiveness Clinical Trials

A Brief Intervention to Improve Cost-effective Resource Use Among Medicine Housestaff

Start date: September 2009
Phase: N/A
Study type: Interventional

OBJECTIVE: To test a brief intervention designed to improve the cost-effectiveness of care provided by medicine housestaff for hospitalized patients. HYPOTHESIS: A brief intervention in which medicine residents receive itemized bills for recent patients cared for by them, followed by a discussion on approaches to reducing unnecessary inpatient costs, can result in significant cost reductions without adversely affecting patient outcomes.

NCT ID: NCT00992368 Completed - Cost-effectiveness Clinical Trials

Cost-effectiveness of Reduction Mammaplasty

Start date: July 2008
Phase: N/A
Study type: Interventional

Several works show breast hypertrophy as pain cause, postural alterations, dermatitis and decrease of the functional capacity and of the self-esteem. The economical evaluations are destined to esteem the costs in alternative ways of attendance to the health, comparing, for instance, clinical strategies with surgical strategies. OBJECTIVE: To analyze cost-effectiveness in reduction mammaplasty.

NCT ID: NCT00366977 Completed - Smoking Cessation Clinical Trials

Efficacy and Cost of State Quitline Policies

Start date: June 2000
Phase: Phase 3
Study type: Interventional

State-sponsored anti-tobacco campaigns are motivating large numbers of smokers to seek advice, assistance, and support to make their cessation efforts more successful. Like many states, Oregon has sponsored the implementation of a statewide telephone quitline to provide information, referrals, and cessation support for callers. This study will answer key policy questions about how to most effectively support smokers who call the Oregon Quitline for assistance. The specific aims are to recruit 4,500 callers to participate in a 3 x 2 randomized trial comparing the cost and cost effectiveness of three levels of behavioral intervention. We will also test two different policies on the availability of nicotine patch therapy. Subjects will be interviewed by telephone at 6 and 12 months to assess smoking status, quit attempts, and use of health plan anc community cessation services. Costs will be assessed separately from the perspectives of the patients, health plans, the State (i.e., Oregon Quitline), and society. Cost per quit and cost per year quality-adjusted years of life saved will be calculated from each of these perspectives.